Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Pneumonia, Ventilator-Associated

• Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABP
• Acyclovir in Mechanically Ventilated Patients With Pneumonia and HSV-1 in BAL
• Oro-nasal Decontamination to Prevent Ventilator-associated Pneumonia
• Human Recombinant Interferon Gamma in the Treatment of Ventilator-acquired Pneumonia in ICU Patients
• Efficacy of Cotrimoxazole as a De-escalation Treatment of Ventilator-Associated Pneumonia in Intensive Care Unit
• PK of BV100 in Patients VABP Suspected or Confirmed to be Due to CRAB
• The Duration of Antibiotic Therapy for Early (DATE) Ventilator Associated Pneumonia (VAP): 4 vs. 7 Days
• HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP Study
• A Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subjects - 2
• Safety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory Disease
• Effect of Statin Therapy on Mortality in Patients With Ventilator Associated Pneumonia
• Antimicrobial Stewardship For Ventilator Associated Pneumonia in Intensive Care
• Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults
• Efficacy and Safety of Selective Digestive Decontamination in the ICU With High Rates of Antibiotic-resistant Bacteria
• Effect of Chlorhexidine-Induced Oral Care on Ventilator-Related Some Respiratory System Complications
• Low Versus High Corticosteroid Use in Ventilator Associated Pneumonia
• Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Pediatric Patients
• The Effect of Supraglottic and Oropharyngeal Decontamination on the Incidence of Ventilator-associated Pneumonia
• Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia
• Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Patients
• Nebulized Colistin for Gram Negative VAP Prevention.
• Use of Aaerosol Combined With Intravenous Antibiotics for the Treatment of Multidrug Resistant GNB Pneumonia
• Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301
• Nebulized Aztreonam for Prevention of Gram Negative Ventilator-associated Pneumonia
• The Effect of Colistin Inhalation on Ventilator Associated Pneumonia
• Short Infusion Versus Prolonged Infusion of Ceftolozane-tazobactam Among Patients With Ventilator Associated-pneumonia
• GRam Stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) Trial
• 7-days Versus 14 Days of Antibiotics Therapy for Ventilator Associated Pneumonia
• Different Oral Colonization of Gram-negative Bacteria in ICU Patients When Using Chlorhexidine at 0.12% Versus Chlorhexidine at 2.0%
• Defining Antibiotic Treatment Duration for Ventilator - Associated Lung Infection
• A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.
• Study Comparing Inhaled Amikacin Versus Placebo to Prevent Ventilator Associated Pneumonia
• Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens
• A Study of Meropenem-Vaborbactam Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia
• Prevention of S. Aureus Pneumonia Study in Mechanically Ventilated Subjects Who Are Heavily Colonized With S. Aureus.
• Nebulized and Intravenous Colistin in Ventilator Associated-pneumonia
• Lung Concentrations of Ceftazidime in Patients With Ventilator-associated Pneumonia
• Aerosolized Plus Intravenous vs. Intravenous Colistin for VAP Due to Pandrugs-resistant A. Baumannii in Neonates
• Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens
• Atropine for Preventing Ventilator-Associated Pneumonia
• Effect of Aerosolised Colistin in Ventilator Associated Pneumonia
• Impact of the Duration of Antibiotics on Clinical Events in Patients With Pseudomonas Aeruginosa Ventilator-associated Pneumonia (iDIAPASON)
• The Pharmacodynamics of Meropenem in Patient With Ventilator-associated Pneumonia
• Effect of Additional Nebulized Amikacin in Ventilator-Associated Pneumonia Caused by Gram Negative Bacteria
• A Pharmacokinetic-pharmacodynamic Dose Comparison Study of 8 mg/kg of Inhaled or Parenteral Gentamicin in 12 Mechanically Ventilated Critically Ill Patients Treated for Ventilator-associated Pneumonia
• Aerosolized Antibiotics in the Treatment of Ventilator Associated Pneumonia
• Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial
• Addition of Tobramycin Inhalation in the Treatment of Ventilator Associated Pneumonia
• Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients
• Antibiotherapy During Therapeutic Hypothermia to Prevent Infectious Complications
• Randomized-controlled Trial (RCT) on Combination Antibiotic for Infections Caused by Gram-negative Bacteria
• Pharmacokinetics, Safety and Efficacy of POL7080 in Patients With Ventilator Associated Pseudomonas Aeruginosa Pneumonia
• Methods of Chlorhexidine Cleansing to Prevent Ventilator-Associated Pneumonia (VAP)
• Safety and Efficacy Study of Ceftolozane/Tazobactam to Treat Ventilated Nosocomial Pneumonia (MK-7625A-008)
• Duration of Antibiotic Treatment for Early VAP (DATE) Trial
• Prehospital Ventilator-Associated Pneumonia Prevention Trial
• Chlorhexidine Gluconate for Prevention of Ventilator Associated Pneumonia in Children.
• The Effect of Ulinastatin on Bronchoalveolar Lavage Fluid of Inflammatory Factors in Patients With Ventilator-associated Pneumonia
• Study of Intravenous Ceftolozane/Tazobactam Compared to Piperacillin/Tazobactam in Ventilator-Associated Pneumonia
• A Study Comparing Ceftazidime-Avibactam Versus Meropenem in Hospitalized Adults With Nosocomial Pneumonia
• Simplified Selective Digestive Tract Decontamination for the Prevention of Intensive Care Unit Acquired Infections
• Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT): A Feasibility Clinical Trial
• Trial of 2% Chlorhexidine Bathing on Nosocomial Infections in the Surgical Intensive Care Unit
• Colistin and Rifampicin for MDR-Acinetobacter
• Early-onset Ventilator-associated Pneumonia in Adults: Comparison of 8 Versus 15 Days of Antibiotic Treatment
• Effect of Atorvastatin on the Frequency of Ventilator-associated Pneumonia in Patients With Ischemic Stroke
• The Population Pharmacokinetics of Imipenem in Patients With Ventilator-associated Pneumonia
• The Pharmacodynamics of Doripenem Between 4-hour and 1-hour Infusion in Patients With Ventilator-associated Pneumonia
• Chlorhexidine Gluconate Oral Care for Adults Experiencing Trauma
• Pharmacodynamics Study of Imipenem in Patients With Ventilator Associated Pneumonia
• Linezolid Alone or Combined With Carbapenem Against Methicillin-resistant Staphylococcus Aureus (MRSA) in Ventilator-associated Pneumonia
• Trial of Colistin Versus Meropenem in Ventilator-associated Pneumonia (VAP) (CR-GNB)
• Antibiotic Prophylaxis for Early Ventilator-associated Pneumonia in Neurological Patients
• A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial Pneumonia
• Oral Care Interventions and Ventilator Associated Pneumonia in Critically Ill Children
• STATIN-VAP STATIN-VAP - STATINs and Ventilator-Associated Pneumonia
• Cost Effectiveness Of Linezolid In Central America
• Tracheobronchitis Prevention Trial
• PROUD Study: A Prospective Study on the Usage Patterns of Doripenem in the Asia Pacific Region
• A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract Infections
• Impact of Imipenem With Amikacin Pharmacokinetic and Pharmacodynamic
• Study of Povidone Iodine to Reduce Pulmonary Infection in Head Trauma and Cerebral Hemorrhage in Intensive Care Unit
• Candida in the Respiratory Tract Secretions of Critically Ill Patients and The Efficacy of Antifungal Treatment
• Study Assessing Immunogenicity and Safety of IC43 In Intensive Care Patients
• Pharmacokinetics of Nebulized Amikacin in Patients With Pneumonia Undergoing Mechanical Ventilation
• Nebulized Ceftazidime and Amikacin in Ventilator Associated Pneumonia
• Open Label Pharmacokinetic in Adult Patients With Ventilator-Associated Pneumonia
• A Clinico-Bacteriological Study and Effect of Stress Ulcer Prophylaxis on Occurrence of Ventilator Associated Pneumonia
• Pravastatin and Ventilatory Associated Pneumonia
• Intravenous Colistin Versus Intravenous Colistin Plus Nebulized Colistin in VAP Due MDR Acinetobacter Baumannii
• Azithromycin as a Quorum-Sensing Inhibitor for the Prevention of Pseudomonas Aeruginosa Ventilator-Associated Pneumonia
• Effect of Oral Decontamination Using Chlorhexidine or Potassium Permanganate in ICU Patients
• Role of Oral Chlorhexidine Gel in Prevention of Ventilator Associated Pneumonia
• To Compare Safety and Efficacy of Doripenem Versus Imipenem-Cilastatin in Patients With Ventilator-Associated Pneumonia
• Microbiologic Response With Linezolid And Vancomycin In Ventilator-Associated Pneumonia Due To Methicillin Resistant Staphylococcus Aureus
• Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia
• A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia
• An Effectiveness, Safety, and Microbiology Study of Doripenem in Patients With Nosocomial (Hospital-acquired) Pneumonia
• Aerosolized Antibiotics and Respiratory Tract Infection in Patients on Mechanical Ventilation
• Intravenous Clarithromycin in Septic Syndrome
• Doripenem in the Treatment of Ventilator-Associated Pneumonia
• Effect of Improved Oral Hygiene to Prevent Pneumonia in Hospitalized Patients
• Trial of Iseganan in Prevention of Ventilator-Associated Pneumonia
• Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia Requiring Mechanical Ventilatory Support